These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 8961238)

  • 41. Medical Complications of Anorexia Nervosa and Bulimia.
    Westmoreland P; Krantz MJ; Mehler PS
    Am J Med; 2016 Jan; 129(1):30-7. PubMed ID: 26169883
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Anticytokine approaches to the treatment of anorexia and cachexia.
    Haslett PA
    Semin Oncol; 1998 Apr; 25(2 Suppl 6):53-7. PubMed ID: 9625384
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Contribution of CNS neuropeptide (NPY, CRH, and beta-endorphin) alterations to psychophysiological abnormalities in anorexia nervosa.
    Kaye WH; Berrettini WH; Gwirtsman HE; Gold PW; George DT; Jimerson DC; Ebert MH
    Psychopharmacol Bull; 1989; 25(3):433-8. PubMed ID: 2533990
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The role of neuropeptides in the disturbed control of appetite and hormone secretion in eating disorders.
    Baranowska B; Wolinska-Witort E; Wasilewska-Dziubinska E; Roguski K; Martynska L; Chmielowska M
    Neuro Endocrinol Lett; 2003 Dec; 24(6):431-4. PubMed ID: 15073570
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Eating disorders: a role for dipeptidyl peptidase IV in nutritional control.
    Hildebrandt M; Rose M; Mönnikes H; Reutter W; Keller W; Klapp BF
    Nutrition; 2001 Jun; 17(6):451-4. PubMed ID: 11399402
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Altered cerebrospinal fluid neuropeptide Y and peptide YY immunoreactivity in anorexia and bulimia nervosa.
    Kaye WH; Berrettini W; Gwirtsman H; George DT
    Arch Gen Psychiatry; 1990 Jun; 47(6):548-56. PubMed ID: 2350207
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cytokines in the pathogenesis of cancer cachexia.
    Argilés JM; Busquets S; López-Soriano FJ
    Curr Opin Clin Nutr Metab Care; 2003 Jul; 6(4):401-6. PubMed ID: 12806213
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Leptin plasma levels in healthy Spanish children and adolescents, children with obesity, and adolescents with anorexia nervosa and bulimia nervosa.
    Argente J; Barrios V; Chowen JA; Sinha MK; Considine RV
    J Pediatr; 1997 Dec; 131(6):833-8. PubMed ID: 9427886
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Risk factors for anorexia nervosa: three integrated case-control comparisons.
    Fairburn CG; Cooper Z; Doll HA; Welch SL
    Arch Gen Psychiatry; 1999 May; 56(5):468-76. PubMed ID: 10232302
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Plasma leptin, neuropeptide Y (NPY) and galanin concentrations in bulimia nervosa and in anorexia nervosa.
    Baranowska B; Wolinska-Witort E; Wasilewska-Dziubinska E; Roguski K; Chmielowska M
    Neuro Endocrinol Lett; 2001 Oct; 22(5):356-8. PubMed ID: 11600878
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Tumor necrosis factor and cachexia: a current perspective.
    Espat NJ; Copeland EM; Moldawer LL
    Surg Oncol; 1994 Oct; 3(5):255-62. PubMed ID: 7889218
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comorbidity of anxiety disorders with anorexia and bulimia nervosa.
    Kaye WH; Bulik CM; Thornton L; Barbarich N; Masters K
    Am J Psychiatry; 2004 Dec; 161(12):2215-21. PubMed ID: 15569892
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Disturbed release of gastrointestinal peptides in anorexia nervosa and in obesity.
    Baranowska B; Radzikowska M; Wasilewska-Dziubinska E; Roguski K; Borowiec M
    Diabetes Obes Metab; 2000 Apr; 2(2):99-103. PubMed ID: 11220530
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Neuropeptide Y: a key molecule in anorexia and cachexia in wasting disorders?
    Inui A
    Mol Med Today; 1999 Feb; 5(2):79-85. PubMed ID: 10200949
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Anorexia and bulimia nervosa in diabetic subjects: more than coincidental.
    Nieuwenhuijzen Kruseman AC
    Neth J Med; 1991 Feb; 38(1-2):1-3. PubMed ID: 2030803
    [No Abstract]   [Full Text] [Related]  

  • 56. [Nutrition and behavioral eating disorders: anorexia and bulimia nervosa].
    Miján de la Torre A; Velasco Vallejo JL
    Nutr Hosp; 1999 May; 14 Suppl 2():81S-91S. PubMed ID: 10548030
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Obsessive-phobic disorders in anorexia and bulimia nervosa].
    Tsivil'ko MA; Korkina MV; Briukhin AE; Bushenina SD; Lineva TIu
    Zh Nevrol Psikhiatr Im S S Korsakova; 1997; 97(3):16-9. PubMed ID: 9157752
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Suicide and attempted suicide in anorexia nervosa and bulimia nervosa].
    Pompili M; Mancinelli I; Girardi P; Accorrà D; Ruberto A; Tatarelli R
    Ann Ist Super Sanita; 2003; 39(2):275-81. PubMed ID: 14587228
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Personality variables and disorders in anorexia nervosa and bulimia nervosa.
    Vitousek K; Manke F
    J Abnorm Psychol; 1994 Feb; 103(1):137-47. PubMed ID: 8040475
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Anorexia nervosa and bulimia nervosa in alcohol-dependent men and women and their relatives.
    Schuckit MA; Tipp JE; Anthenelli RM; Bucholz KK; Hesselbrock VM; Nurnberger JI
    Am J Psychiatry; 1996 Jan; 153(1):74-82. PubMed ID: 8540597
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.